Kaleido Biosciences Executives
Kaleido Biosciences employs about 76 people. The company is managed by 3 executives with a total tenure of roughly 178 years, averaging almost 59.0 years of service per executive, having 25.33 employees per reported executive. Analysis of Kaleido Biosciences' management performance can provide insight into the firm performance.
| Mark Wingertzahn Insider VP Devel |
| Kimberly Hocknell Insider VP Operations |
Kaleido |
Kaleido Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.9993) % which means that it has lost $0.9993 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.8057) %, meaning that it created substantial loss on money invested by shareholders. Kaleido Biosciences' management efficiency ratios could be used to measure how well Kaleido Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Kaleido Biosciences Workforce Comparison
Kaleido Biosciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 702. Kaleido Biosciences retains roughly 76.0 in number of employees claiming about 11% of equities under Health Care industry.
Kaleido Biosciences Notable Stakeholders
A Kaleido Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kaleido Biosciences often face trade-offs trying to please all of them. Kaleido Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kaleido Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Mark Wingertzahn | VP Devel | Profile | |
| Kimberly Hocknell | VP Operations | Profile | |
| LLM JD | Chief Advisor | Profile |
Kaleido Biosciences Workforce Analysis
Traditionally, organizations such as Kaleido Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kaleido Biosciences within its industry.Kaleido Biosciences Manpower Efficiency
Return on Kaleido Biosciences Manpower
| Revenue Per Employee | 14.5K | |
| Revenue Per Executive | 368K | |
| Net Loss Per Employee | 1.2M | |
| Net Loss Per Executive | 30.1M | |
| Working Capital Per Employee | 822.9K | |
| Working Capital Per Executive | 20.8M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Kaleido Pink Sheet
If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |